Avitas Wealth Management LLC purchased a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the fourth quarter, Holdings Channel reports. The firm purchased 1,065 shares of the biopharmaceutical company’s stock, valued at approximately $204,000. A number of other institutional investors and hedge funds also recently made changes to their positions […]
Avitas Wealth Management LLC acquired a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,065 shares of the biopharmaceutical company’s stock, valued at approximately $204,000. A number of […]
Howland Capital Management LLC acquired a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 4,000 shares of the biopharmaceutical company’s stock, valued at approximately $766,000. Several other hedge funds and other institutional […]
Karani Asset Management LLC lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 24.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,555 shares of the biopharmaceutical company’s stock after selling 3,690 shares during the quarter. Alnylam Pharmaceuticals comprises […]
StockNews.com downgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a strong-buy rating to a buy rating in a report published on Wednesday. A number of other research analysts have also recently commented on ALNY. William Blair restated an outperform rating on shares of Alnylam Pharmaceuticals in a research note on Monday, January 8th. […]